SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
5,025.00    470.00 (10.56%)
Bid:
5,000.00
Ask:
5,050.00
Spread: 50.00 (1.00%)
Market Cap: £327.71m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Board Change

10 Sep 2020 07:00

RNS Number : 5444Y
Judges Scientific PLC
10 September 2020
 

Press Release

 

 

 

Judges Scientific plc

 

("Judges Scientific")

 

Board Change

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces the appointment of Lushani Kodituwakku as an independent Non-Executive Director from 23 September 2020.

Lushani is the founder and CEO of Luminii Consulting, a consulting firm specialising in strategy, Commercial Due Diligence ("CDD") and value creation. She founded Luminii in 2017 after setting up and heading the Grant Thornton Strategy and CDD team in 2008 and holding various other senior roles with KPMG, Frost & Sullivan, PMSI and Neovian Partners.

Lushani has delivered several complex strategy & CDD projects since 1999 to large corporates, SMEs, private equity, venture capital and banks in the UK, Europe and USA looking to invest, enter new markets, diversify, redefine their business strategy and business models, making her one of the most experienced CDD and strategy advisors in the UK.

Lushani holds a Bachelor of Science (BSc) in Economics with first-class honours, and a Master of Research (MRes) in Management and Organisational Behaviour.

Lushani will also join the Remuneration committee, replacing Alex Hambro. The Board committees will comprise as follows:

Remuneration committee - Charles Holroyd (chair), Ralph Elman, Lushani Kodituwakku

Audit committee - Ralph Elman (chair), Charles Holroyd, Ralph Cohen

 

Commenting on the appointment, Alex Hambro, Chairman of Judges, said

"We are delighted to welcome Lushani to the Group. Lushani brings extensive expertise in strategy, CDD and value creation. We look forward to her guidance over the coming years as the Group continues to execute its buy and build growth strategy."

 

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

  Tel: +44 (0) 20 3829 6970

 

Shore Capital (Nominated Adviser & Joint Broker)

 

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Alma (Financial Public Relations)

Rebecca Sanders-Hewett

Sam Modlin

 

 

Tel: +44 (0) 20 3100 2222

 

 

 

 

Tel: +44 (0) 20 3405 0205

 

 

Regulatory Information

The following disclosures in relation to the appointment of Lushani Dileeka Kodituwakku, aged 46, are required pursuant to Schedule 2(g) of the AIM Rules for Companies:

 

 Current directorships and partnerships:

Past directorships and partnerships held over the last five years:

Anukampa Bhikkhuni Project

 

Ceylon Tea Centre Limited

 

Luminii Consulting

 

 

Lushani Kodituwakku has confirmed that there is no other additional information to be disclosed under Schedule 2 (g) of the AIM Rules.  

 

 

Notes to editors: 

 

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 18 businesses acquired since it was re-admitted to AIM in 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEAAIIAIII
Date   Source Headline
29th Jul 20093:53 pmRNSShare buyback programme
29th Jul 20099:45 amRNSDirector/PDMR Shareholding
28th Jul 20099:55 amRNSHolding(s) in Company
27th Jul 20097:00 amRNSDirector/PDMR Shareholding
24th Jul 20098:38 amRNSDirector/PDMR Shareholding
20th Jul 20097:00 amRNSTrading Statement
2nd Jul 20095:30 pmRNSHolding(s) in Company
18th Jun 200912:54 pmRNSFurther re Acquisition
10th Jun 20097:00 amRNSAcquisition
22nd May 20093:13 pmRNSAGM Statement
30th Apr 20091:54 pmRNSAnnual Financial Report
30th Mar 20097:00 amRNSFinal Results
30th Jan 20099:04 amRNSShare buyback programme
21st Jan 20097:00 amRNSTrading Statement
17th Dec 20082:46 pmRNSDirectorate Change
17th Nov 20087:00 amRNSAcquisition activity
26th Aug 20087:00 amRNSInterim Results
22nd Aug 200810:50 amRNSNotice of Results
15th Jul 20087:00 amRNSTrading Statement
13th Jun 20084:51 pmRNSHolding(s) in Company
13th Jun 20084:25 pmRNSHolding(s) in Company
13th Jun 20083:16 pmRNSHolding(s) in Company
9th Jun 20084:22 pmRNSFurther re Issue of Equity
22nd May 20087:00 amRNSAGM Statement
21st May 20087:00 amRNSIssue of Equity
29th Apr 20087:01 amRNSDirector/PDMR Shareholding
28th Apr 20085:28 pmRNSCirc re. Panel Waiver
28th Mar 20087:01 amRNSFinal Results
25th Mar 20087:01 amRNSFreehold property purchase
29th Jan 20087:00 amRNSPre Close Trading Statement
30th Nov 20077:01 amRNSDirector/PDMR Shareholding
27th Nov 20077:01 amRNSDirector/PDMR Shareholding
4th Oct 20077:01 amRNSDirector/PDMR Shareholding
25th Sep 20071:25 pmRNSGrant of Options/Dir holding
21st Sep 20077:02 amRNSInterim Results
9th Aug 20074:31 pmRNSHolding in Poole Investments
2nd Aug 20074:33 pmRNSCompany Website
21st May 20075:54 pmRNSResult of AGM
23rd Mar 20077:01 amRNSPreliminary Results
16th Mar 20077:00 amRNSNotice of Preliminary Results
9th Jan 20077:00 amRNSTrading Statement
21st Dec 20061:49 pmRNSTotal Voting Rights
7th Nov 20063:12 pmBUSRule 8.3 - Corus Group PLC
27th Oct 20062:29 pmBUSRule 8.3 - Corus Group PLC
26th Sep 20067:03 amRNSInterim Results
22nd Sep 20067:00 amRNSNotice of Results
5th Sep 20067:02 amRNSAcquisition
28th Mar 200612:31 pmRNSDirector/PDMR Shareholding
21st Mar 20067:01 amRNSFinal Results
21st Mar 20067:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.